Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD2 Antikörper

CD2 Reaktivität: Human FACS, IHC, Func Wirt: Maus Monoclonal B-E2 unconjugated
Produktnummer ABIN1383690
  • Target Alle CD2 Antikörper anzeigen
    CD2
    Reaktivität
    • 169
    • 36
    • 17
    • 16
    • 12
    • 10
    • 10
    • 6
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 138
    • 45
    • 24
    • 2
    Maus
    Klonalität
    • 163
    • 44
    • 2
    Monoklonal
    Konjugat
    • 87
    • 24
    • 22
    • 18
    • 9
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CD2 Antikörper ist unkonjugiert
    Applikation
    • 148
    • 53
    • 53
    • 37
    • 33
    • 32
    • 21
    • 13
    • 11
    • 11
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (IHC), Functional Studies (Func)
    Spezifität
    Recognises the Lymphocyte Function associated Antigen-2 (LFA-2), a 50 kDa protein
    Aufreinigung
    Ion exchange chromatography
    Sterilität
    0.22 μm filtered
    Immunogen
    Human thymocytes,Myeloma X63/AG.8653 x Balb/c spleen cells
    Klon
    B-E2
    Isotyp
    IgG2b, kappa
    Biological Activity Comment
    Inhibits mixed lymphocyte culture
    Top Product
    Discover our top product CD2 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
    Konservierungsmittel
    Without preservative
    Lagerung
    4 °C
    Informationen zur Lagerung
    Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
  • Dupuis-Girod, Cancrini, Le Deist, Palma, Bodemer, Puel, Livadiotti, Picard, Bossuyt, Rossi, Fischer, Casanova: "Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency." in: Pediatrics, Vol. 118, Issue 1, pp. e205-11, (2006) (PubMed).

    Tiberghien, Ferrand, Lioure, Milpied, Angonin, Deconinck, Certoux, Robinet, Saas, Petracca, Juttner, Reynolds, Longo, Hervé, Cahn: "Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft." in: Blood, Vol. 97, Issue 1, pp. 63-72, (2001) (PubMed).

    Przepiorka, Phillips, Ratanatharathorn, Cottler-Fox, Sehn, Antin, LeBherz, Awwad, Hope, McClain: "A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease." in: Blood, Vol. 92, Issue 11, pp. 4066-71, (1999) (PubMed).

    Jabado, de Graeff-Meeder, Cavazzana-Calvo, Haddad, Le Deist, Benkerrou, Dufourcq, Caillat, Blanche, Fischer: "Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors." in: Blood, Vol. 90, Issue 12, pp. 4743-8, (1997) (PubMed).

    Cavazzana-Calvo, Bordigoni, Michel, Esperou, Souillet, Leblanc, Stephan, Vannier, Mechinaud, Reiffers, Vilmer, Landman-Parker, Benkerrou, Baruchel, Pico, Bernaudin, Bergeron, Plouvier, Thomas, Wijdenes, Lacour, Blanche, Fischer: "A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse." in: British journal of haematology, Vol. 93, Issue 1, pp. 131-8, (1996) (PubMed).

    Jabado, Le Deist, Cant, De Graeff-Meeders, Fasth, Morgan, Vellodi, Hale, Bujan, Thomas, Cavazzana-Calvo, Wijdenes, Fischer: "Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection." in: Pediatrics, Vol. 98, Issue 3 Pt 1, pp. 420-8, (1996) (PubMed).

    Racadot, Milpied, Bordigoni, Cahn, Plouvier, Lioure, Lutz, Wijdenes, Herve: "Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients." in: Bone marrow transplantation, Vol. 15, Issue 5, pp. 669-77, (1995) (PubMed).

  • Target
    CD2
    Andere Bezeichnung
    CD2 (CD2 Produkte)
    Synonyme
    CD2 antikoerper, LFA-2 antikoerper, Ly-37 antikoerper, Ly37 antikoerper, SRBC antikoerper, T11 antikoerper, CD2R antikoerper, LFA2 antikoerper, OX-34 antikoerper, OX34 antikoerper, CD2 molecule antikoerper, CD2 antigen antikoerper, Cd2 molecule antikoerper, CD2 antikoerper, Cd2 antikoerper
    Hintergrund
    LFA-2
    Molekulargewicht
    50 kDa
Sie sind hier:
Kundenservice